Summit Partners Public Asset Management »

Arrowhead Pharmaceuticals shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $45M 670k 66.39

More positions owned by Summit Partners Public Asset Management

Sandisk Corp Put Option (SNDK)
Insmed Com Par $.01 (INSM)
Mongodb Cl A Put Option (MDB)
Spotify Technology S A SHS (SPOT)
NVIDIA Corporation Call Option (NVDA)
Carvana Cl A Call Option (CVNA)
Solaris Energy Infras Com Cl A (SEI)
Ge Vernova (GEV)
Credo Technology Group Holdi Ordinary Shares Put Option (CRDO)
Tower Semiconductor Shs New (TSEM)
Ionis Pharmaceuticals Put Option (IONS)
Genedx Holdings Corp Com Cl A (WGS)
Cidara Therapeutics Com New (CDTX)
Jfrog Ord Shs (FROG)
Natera (NTRA)

View all positions for Summit Partners Public Asset Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Geode Capital Management
Siren
Slate Path Capital
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Deerfield Management Company
Norges Bank Investment Management
Goldman Sachs Group
Baker Bros. Advisors
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals